T1	Participants 161 216	52-mg levonorgestrel intrauterine contraceptive (LNG20)
T2	Participants 262 380	Nulliparous and parous women aged 16-45 years at enrollment with regular menstrual cycles and requesting contraception
T3	Participants 588 593	LNG20
T4	Participants 738 823	1600 women aged 16-35 years and 151 women aged 36-45 years agreed to LNG20 placement,
T5	Participants 1648 1676	nulliparous and parous women
